Duailibe, Felipe
Shen, Tian
Zhang, Wendy
Moore, David
Hull, Mark
Barath, Justin
Magee, Carly
Lachowsky, Nathan
Hart, Trevor
Cox, Joseph
Grace, Daniel
Lambert, Gilles
Skakoon-Sparling, Shayna
Jollimore, Jody
Dvorakova, Milada
Gormezano, Aki
Lima, Viviane Dias https://orcid.org/0000-0003-4943-091X
Funding for this research was provided by:
Canadian Institutes for Health Research (TE2-138299, PJT-156147, Canadian Institutes for Health Research)
Canadian Foundation for AIDS Research (Canadian Foundation for AIDS Research)
Ontario HIV Treatment Network (1051, Ontario HIV Treatment Network)
Public Health Agency of Canada (4500345082)
Toronto Metropolitan University (Toronto Metropolitan University)
Michael Smith Health Research BC (16863;5209)
Article History
Accepted: 10 May 2025
First Online: 23 May 2025
Declarations
:
: Ethics approval was acquired from the Providence Health Care Research Ethics Board (H18-00949) and all the institutions of the principal investigators of the Engage study: Toronto Metropolitan University, the University of Toronto, St. Michael’s Hospital, the University of Windsor, the University of British Columbia, the University of Victoria, Simon Fraser University, and the McGill University Health Centre.
: VDL received honoraria to present at the 2023 CROI (Conference on Retroviruses and Opportunistic Infections) ViiV Healthcare Ambassador Program. T.A.H. was supported by an Endgame Leader Chair Award in Gay and Bisexual Men’s Health from the Ontario HIV Treatment Network. D.M.M. and N.J.L. are supported by Scholar Awards from the Michael Smith Foundation for Health Research (5209, 16863). T.A.H. has received unrestricted educational grants from ViiV Health, Gilead, and DECIEM. S.S.-S. is supported by a CIHR postdoctoral fellowship award. D.G. is supported by a Canada Research Chair in Sexual and Gender Minority Health. D.H.S.T. is supported by a Tier 2 Canada Research Chair in HIV Prevention and STI Research. J.M.S. was supported by a CTN postdoctoral fellowship award